News

Stay informed about our scientific advances, clinical progress, and company updates.

Press Release
November 12, 2026

Apmonia Therapeutics announces first patient treated in Phase 1/2a study of TAX2, a new approach to cancer immunotherapy

Read more
Cover of the Apmonia Therapeutics press release of 12 November 2026
Cover of the Apmonia Therapeutics press release of 12 November 2026
Press Release
November 12, 2026

Apmonia Therapeutics announces first patient treated in Phase 1/2a study of TAX2, a new approach to cancer immunotherapy

Read more
Cover of the Apmonia Therapeutics press release of February 3, 2026
Press Release
February 3, 2026

Apmonia Therapeutics secures €10 million to advance first-in-human development of first-in-class cancer therapy TAX2

Read more
Illustration of computational modeling of a protein interaction
Press Release
December 16, 2024

Apmonia Therapeutics strengthens its drug discovery capabilities and extends its collaboration with the Max Mousseron Institute of Biomolecules (IBMM)

Read more
Press Release
July 16, 2024

Apmonia Therapeutics to receive €2.5m grant and €7m equity investment from the European Innovation Council (EIC) as a laureate of the EIC Accelerator program

Read more
Press Release
April 23, 2024

Apmonia Tx announces a €2.7M financing to develop its clinical candidate and strengthen its discovery platform

Read more
Press Release
September 12, 2023

Apmonia Therapeutics announces a new licensing agreement with SATT Nord to strengthen its portfolio of innovative peptides for oncology

Read more
Press Release
July 11, 2023

Apmonia Therapeutics appoints Professor Liliana Schaefer to Scientific and Clinical Advisory Board

Read more
Press Release
December 5, 2022

Apmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR (French National Research Agency)

Read more
Press Release
September 2, 2022

Apmonia Therapeutics announces a €2.5 million financing to develop its lead candidate targeting solid cancers

Read more
Press Release
February 10, 2022

Apmonia Therapeutics announces a 4 M€ fundraising round

Read more
Press Release
February 10, 2022

Apmonia Therapeutics annonce une nouvelle levée de fonds de 4 M€

Read more
Illustration of a tumor cell surrounded by extracellular matrix
Publications
October 14, 2021

New Scientific Publication

Read more
Structure of the TAX2 cyclic peptide
Publications
December 1, 2020

New Scientific Publication

Read more
Overall news
September 22, 2020

Business Angels Marne-Ardennes

Read more
Press Release
July 28, 2020

Apmonia Tx Press release

Read more
Overall news
July 28, 2020

i-Lab 2020 Award

Read more
Overall news
July 2, 2020

Cancer Biology and Basic Sciences

Read more
Overall news
December 18, 2019

Welcome to Reims 2019

Read more
Overall news
September 25, 2019

A new drug candidate in the fight against cancer

Read more

No results